knowledge -WSS

knowledge

author：knowledge 2025-09-03 14:35:24 - browse：94539

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Asbestos, a deadly carcinogen, banned by EPA

WSS

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Orchard's therapy for neuron disease in children wins FDA approval

Nurses recount patients attacks

Who gets to use the title 'doctor'?

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Why police arrested suspected Gilgo Beach killer away from his house

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Plastic surgeons increase patient psychiatric screenings

DIEP, the 'gold standard' of breast reconstruction, is under threat

Involuntary treatment for addiction doesn't work

Affirmative action in medical school literally saved lives

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

The high cost of giving birth even with insurance

Asbestos, a deadly carcinogen, banned by EPA

ChatGPT in medicine: STAT answers readers' burning questions

Positive childhood experiences can help future health

entertainment

Baby aspirin cuts fat buildup in liver disease patients, in small study

Can CDC director Mandy Cohen drive consensus in Washington?

Grail faces three suits alleging harassment, retaliation

Mike Pence clashes with Tucker Carlson in Iowa

Colonoscopy prep: Liquid

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

focus

leisure time

explore

hotspot